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Center Hosts Conference on
“Safer” Tobacco Products
In this issue of Tobacco RegulationReview, we report on our recentactivities and accomplishments.  The
Center’s April 2007 conference on “safer”
tobacco products attracted legal academics,
tobacco and public health experts, and
scientists from around the country.
Presenters debated the legal issues and
possible regulatory approaches to dealing
with new tobacco products being marketed
as safer than traditional products.  The
conference presenters and attendees took
different positions on this controversial
topic, generated much discussion, and
made clear that  the debate must continue
on this emerging issue.
Also, last spring, the Maryland
Legislature passed the Clean Indoor Air
Act, a law that will result in smokefree
public places and workplaces across the
State as of February 1, 2008.  The Center is
currently working with the Department of
Health and Mental Hygiene to craft
regulations that protect the  public and
workers from exposure to secondhand
smoke in accordance with the intent of the
General Assembly.  The advocates who
worked tirelessly for years to gain passage
of the Act deserve our thanks and praise.
Another success during the legislative
session was passage of the Cigarette Fire
Safety and Fire Fighter Protection Act.  The
State will reap the benefits of this law soon
after the July 2008 effective date.
Details of the conference and each
of the Acts along with other news of the
Center’s work are included in this issue.
On April 20, 2007, more than 75 members of the tobaccocontrol community
throughout the United States
gathered to hear experts and
advocates from the fields of public
health, science, communications,
and law discuss the timely issue of
harm reduction.  At the day-long
conference, “Safer” Tobacco
Products:  Reducing Harm or
Giving False Hope? speakers
presented varying viewpoints on a
controversial issue: whether, with
respect to protecting individual and
public health from the dangers of
tobacco, there is a middle ground—
in the form of potentially reduced
exposure products (PREPs).
PREPs  are tobacco products
marketed by manufacturers as
having fewer harmful health effects
than traditional cigarettes.  One
example is R.J. Reynolds’ Eclipse
cigarette, which Reynolds claimed
“may present less risk of cancer,
chronic bronchitis, and possibly
emphysema.” (See
www.eclipse.rjrt.com (requires log-in
ID). )
     Mitch Zeller of Pinney
Associates kicked off the day
speaking about the historical
evolution of the tobacco industry’s
marketing of ostensibly lower harm
products. The industry responded to
the first publicly documented health
scare about smoking in the same way
that it continues to respond today:
with a technological innovation the
Dr. Cheryl Healton, CEO of the American Legacy Foundation, speaks to attendees.
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manufacturers claim is a good-faith
response to health concerns. In the
1950s, it was the Kent Micronite
filter, which contained a form of
asbestos, a carcinogen that smokers
inhaled along with the tobacco
smoke, thus negating any reduction
in harm.  In the 1960s and 1970s,
light and lower tar cigarettes were
the allegedly healthier alternatives
produced and marketed to
concerned smokers. The claims
about these products were
unfounded and possibly led to
greater harm, as smokers who
otherwise would have quit
unsuspectingly switched to brands
that were just as bad for them.
Zeller emphasized that failures such
as these are prime examples of what
can happen in an unregulated
marketplace where companies are
free to make any product
modification or health claim in
advertising, marketing, and
promotion.
     Dr. Peter Shields of
Georgetown University Medical
Center explained the science behind
risk reduction products. Shields
illustrated how past studies on the
purported health benefits of light or
low tar cigarettes were flawed. He
also acknowledged important
unanswered questions regarding how
PREPs should be studied and
evaluated.  For example, he asked:
How much uncertainty do we
accept, in light of tobacco use’s huge
public health implications? How
much reduction in exposure is
enough? What are the best methods
to measure decreased exposure and
to predict decreased risk? Does
everyone benefit equally from
switching to a PREP? How do we
balance benefits to the individual
versus harm to the population?
     Conceding that the only true way
to gauge the success of PREPs
would be to conduct long-term
epidemiological studies on human
smokers, Shields was quick to
dismiss this option, due to
impracticality and ethical concerns.
Instead, he theorized a tiered system
of measures he believes would
constitute adequate research before
a company could make any health
claim about a particular tobacco
product.
     Bill Godshall of Smokefree
Pennsylvania discussed smokeless
tobacco as a harm reduction
product. He first noted that there is
relatively little risk reduction when
combustion of a tobacco product
occurs. After presenting historical
data on tobacco use, Godshall
asserted that, “Smokeless tobacco
products are clearly less hazardous
than cigarettes, and smokers don’t
know about [the reduced harm],
they need to know about it, and
the public health community needs
to be telling them about it.”
     Godshall took the global public
health community to task for its
uncompromising stance that
smokeless tobacco is not a safer
alternative to smoking.
     Switching gears, Micah
Berman of the Tobacco Public
Policy Center outlined potential
legal responses—in terms of
regulation and litigation—to cigarette
manufacturers moving into the
smokeless tobacco market. Context
and motive matter, both in light of
these companies’ histories and
because their mission is to increase
profits, not to advance harm
reduction.  Berman stressed that
there should be consensus within the
public health community that any
potential harm reduction would be
undercut if the product is marketed
to youth, never-smokers, or former
smokers; is used in addition to, and
 Micah Berman discusses enforcement of MSA provisions for new smokeless
products.
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not instead of, smoking; or is not as
safe as possible.
     Berman highlighted potential
enforcement of the Master Settlement
Agreement’s prohibitions on youth
targeting, free giveaways, and health
claims, relating to both cigarettes and
smokeless tobacco products. So far,
signatories have been careful and
wise not to make any health claims
about their smokeless products.  As
for litigation options, there hasn’t yet
been a successful health-related
lawsuit regarding smokeless tobacco.
     David Sweanor of the University
of Ottawa presented: The Basis of a
Comprehensive Regulatory Policy
for Reduced Harm Tobacco
Products.  In Sweanor’s view, while
it is the job of medical professionals
to identify the cause of disease and to
seek remedies, it is the responsibility
of attorneys, public health leaders,
and legislators to adopt and
implement public policy that respects
individual rights and interests while
reducing the societal impact of the
disease. Tobacco use and its related
health risks fit this pattern.
     Sweanor illustrated how Canada’s
successful tobacco control-public
health movement led to the country’s
60 percent decline in smoking over
the last 25 years. But the fact that
millions of Canadians continue to
smoke and many will die prematurely
from smoking raises the question at
the heart of the conference: What
should be the focus of our efforts to
achieve public health success—
eliminating tobacco use or reducing
the harm caused by its use?
     Accepting the reality that tobacco
use will persist requires foregoing the
favored abstinence-only paradigm
to tobacco use — ”just quit”—
and moving to a pragmatic,
science-based public health
approach that will reduce the risk
of harm to the users who cannot or
will not quit, and the harm to those
around them. Sweanor implored
tobacco control and public health
advocates to learn from past
successes in regulating the safety of
food, pharmaceuticals, and
automobiles. While it is important
to ensure that consumers are given
factual information, consumer
protection fears and litigation
should not be allowed to halt the
development of safer products or
the creation of effective public
health campaigns about reducing
harm while still using tobacco.
     At lunchtime, attendees were
treated to a provocative keynote
speech from Dr. Cheryl Healton
of the American Legacy
Foundation. Healton focused on
reduced harm programs in other
areas of public health, such as
HIV/AIDS, to demonstrate the
fallacy of the all-or-nothing
approach.
     Dr. Richard Daynard of the
Public Health Advocacy Institute
led off the afternoon with a talk on
potential litigation strategies with
respect to health claims PREP
manufacturers may make. After
setting out the current state of
tobacco litigation, Daynard
distinguished the challenges of
future litigation over reduced risk
products.
     Daynard noted how the current
allegedly safer products—light
cigarettes—have gotten the
tobacco industry into trouble, with
juries finding companies liable for
fraud and awarding large amounts of
damages to plaintiffs injured by that
fraud. Whether new, safer products
will spawn similar litigation depends
on how the products are marketed
and whether they are really safer. If
Congress grants the U.S. Food &
Drug Administration (FDA) authority
to regulate tobacco products,
reduced-risk products that are FDA-
approved and marketed consistently
with FDA requirements could become
legally bullet-proof. Manufacturers
will be able to use government
regulation as a defense against the
imposition of punitive damages.
     On the other hand, marketing a
genuinely safer tobacco product could
put at legal risk products that are less
safe.  It would demonstrate the
availability of an alternative design to
conventional cigarettes, leading to
possible strict product liability suits. It
also raises the question why the
industry failed to manufacture a safer
product earlier and apply it to the
whole product line, rather than to
select products, resulting in a viable
negligence claim.
     Daynard predicted that,  in
general, despite some negative
aspects, the FDA bill being
considered in Congress at the time
(changes have been made to that bill
since April) would have very little
impact on litigation. Pharmaceutical
companies, for example, have been
regulated for a century yet still get hit
with big verdicts.
     Geoffrey Ferris Wayne of the
Harvard School of Public Health
spoke on the role harm reduction
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products play in tobacco industry
strategy. He raised a number of
questions about this issue:
•     What market considerations
provide the primary motivation
behind development of PREPs—the
threat of litigation or anticipated
regulation, the need to expand or
develop new markets, and/or
competition among manufacturers?
•     Are PREPs different from other
product innovations such as
Marlboro Ultra Smooth (MUS)?
•     Are PREPs developed in
response to the same or different
market considerations as other
product innovations?
The answers may be found in
market/analyst reports and the
tobacco industry’s own public
statements, internal documents, and
trial testimony.
     Given data gleaned from
tobacco industry testimony, Ferris
Wayne speculated that products
like MUS may simply be intended
to blur the line between
conventional and reduced harm.
Proliferation of new products
supports the industry’s attitude that
consumers are responsible for
“choosing” harm reduction.
Continued development of
alternative tobacco products and
technologies supports market
expansion through starter products
and protects the current market by
reducing the impact of use
restrictions like indoor smoking
bans. Perhaps more insidious, the
expansion of variations within a
particular class of product enables
the industry to perpetuate a
continuum where seemingly “safer”
products are placed in the same
market as “less safe” or conventional
ones.
      Lessons learned from the
industry’s own communications
suggest that tobacco control and
public health advocates should do
away with what Ferris Wayne claims
is a “false continuum of safety” and
put all products “on the same plane”.
While it is acceptable to contrast the
very different products of smokeless
and combustible tobacco, he insists
that “there is a problem when we
have products that are along a sort
of registry of less harmful, slightly
less harmful, and full harm” within the
same generic class.
     Mitch Zeller took the podium a
second time to discuss Philip Morris’
efforts to counteract its plummeting
image in the early 1990s by adopting
a social responsibility campaign.
Using internal company documents,
Zeller outlined a case study of a
corporate phoenix rising from the
ashes.
      Chris Bostic of the Framework
Convention Alliance, and Dr. Vera
da Costa e Silva of the
PanAmerican Health Organization
addressed international perspectives
on PREPs. Bostic spoke on the
terms of the Framework Convention
on Tobacco Control and Dr. Costa e
Silva explained the World Health
Organization’s stance on PREPs.
      Articles based on presentations
made by several speakers at the
conference will be published in an
upcoming symposium issue of the
Journal of Health Care Law &
Policy. To obtain materials from the
conference, contact Jackie
McNamara at (410) 706-3962 or
jmcnamara@law.umaryland.edu.
Continued from page 4
MARYLAND
HAPPENINGS
2007 General Assembly
Session
     The 2007 Session of the
Maryland General Assembly, running
from January 10 through midnight
April 9, was the first of a four-year
term for the 188 member State
legislature, which included 11 new
senators and 34 new delegates. The
election of so many freshman
legislators marked a new start in a
number of ways. Significant changes
in committee memberships, which
allowed for fresh perspectives on
previously considered bills, were
made to accommodate the new
members. For the tobacco control
community, these changes created a
good opportunity to get lingering
tobacco control initiatives passed.
The following summarizes each
introduced tobacco control bill and
its disposition.
Continued on page 6
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     Senate Bill 91/House Bill 359
– Clean Indoor Air Act (CIA).
After a few substantive changes
from previous incarnations, a bill
designed to close the loophole in
state law allowing smoking inside
enclosed bars and restaurants was
introduced for the fifth consecutive
year.  Senator Rob Garagiola served
as the bill’s new lead sponsor in the
Senate. Senator Garagiola’s new
assignment to the Finance
Committee gave the bill an in-
committee sponsor for the first time.
Delagate Barbara Frush again
served as lead sponsor in the House
where the bill was heard by the
Economic Matters Committee, a
change from the previous years
when the bill was heard by the
Health and Government Operations
Committee.
     After Baltimore City passed its
own local CIA bill mid-session, the
stalled statewide bill gained  new
momentum in both chambers. For
the first time, the cross-filed bills
passed out of their respective
committees, each with slightly
different amendments. Ultimately, the
House version passed on a 99-39
vote, and the Senate version passed
on a 33-13 vote. With neither
chamber willing to concede, the
different versions were sent to
Conference Committee, where
discrepancies were resolved.
Representatives Garagiola, Exum,
and Astle from the Senate, and
Davis, Krysiak, and Vaughn from
the House, agreed on a version
which prohibits smoking in nearly all
indoor public and work places,
including private clubs; exempts
retail tobacco shops; allows local
public health officers to grant
hardship waivers based on state-
issued regulations, with all waivers
expiring January 31, 2011; and
explicitly affirms the ability of local
jurisdictions to pass more stringent
smoking restrictions. The
compromise bill passed both
chambers (100-40 House/33-16
Senate) and was signed into law on
May 17, 2007. The law will go into
effect February 1, 2008.
     Senate Bill 361/House Bill
785 – Cigarette Fire Safety and
Fire Fighter Protection Act.
Following a last- minute procedural
delay that opponents used to kill a
similar bill in the Senate last year,
legislators, fire fighters, and public
health advocates introduced cross-
filed bills requiring all cigarettes sold
in Maryland to meet the same
“ignition propensity” standards as
those sold in California, Illinois,
Massachusetts, New Hampshire,
New York, and Vermont (see
related story in Tobacco Regulation
Review, Volume 4, Issue I, page
10). Delegate Malone and Senator
Lenett served as lead sponsors, with
87 legislators co-sponsoring. Some
technical changes to the prior year’s
bill also brought a new advocate to
the table:  cigarette manufacturer
Philip Morris.  Despite some rocky
moments, the House (136-1) and
Senate (47-0) overwhelmingly
passed the bills, which were signed
into law May 17, 2007. The law will
go into effect July 1, 2008, in order
to give the State Fire Prevention
Commission and Comptroller time
to promulgate regulations to ensure
compliance. At that time, Maryland
retailers will begin selling down the
last of their existing inventories, and
shortly thereafter, all cigarettes sold
Continued from page 5
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Clean Indoor Air Act signing.
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in Maryland will meet fire safety
standards,  likely reducing
unnecessary deaths and property
loss from cigarette-caused fires.
     Senate Bill 835/House Bill
807 – Supersedeas Bonds
Limitation.  For the third year in a
row, cross-filed bills were
introduced seeking to cap the
amount of a bond a party appealing
an adverse civil judgment must post
in order to stay (postpone)
enforcement of that judgment during
appeal. This year’s version sought to
cap the maximum bond amount at
$100 million, regardless of the
judgment amount in the underlying
civil action. The bill was primarily
driven and supported by the
tobacco industry. Once again, the
Center testified in opposition,
labeling the bill as largely
unnecessary because Maryland law
already provides judges with the
discretion to limit bonds where
appropriate. The House Judiciary
Committee gave the bill an
unfavorable report after a hearing in
which Delegate Simmons rigorously
questioned tobacco industry
representatives. The defeat maintains
Maryland’s status as one of a few
states without a cap on appeals
bonds.
     Senate Bill 1017 – Tobacco
Paraphernalia Distribution to
Minors.  In early March, the
legislature became aware of a quirk
in the law prohibiting the sale of
tobacco products and cigarette
rolling papers to minors that
implicitly authorized the sale of water
pipes and other tobacco
paraphernalia to minors. Because
the deadline to introduce new
legislation had passed, emergency
legislation was introduced to close
this loophole. The bill sailed through
both chambers, passing the Senate
(47-0) and House (139-0)
unanimously, and was signed into law
April 24, 2007. Because this was an
emergency bill,  it went into effect
immediately upon approval.
     House Bill 447 – St. Mary’s
Civil Citation for Sale of Tobacco
to Minors.  For more than three
decades, Maryland law has
prohibited the sale of tobacco
products to minors. The penalties
attached to the state law are criminal
in nature, requiring enforcement by a
licensed police officer, a criminal trial
by the state’s attorney, and result in a
criminal record for those convicted.
Despite detecting an inordinate
number of youth sales, St. Mary’s
County judges were reluctant to
convict under the state law, finding
the penalties overly harsh compared
to the offense. Thus, St. Mary’s
County sought to join five other
Maryland jurisdictions in passing a
local civil sales law. Applying only to
St. Mary’s County, this bill was
substantively identical to current state
law except that it provided for civil
penalties, freeing up police and
judicial resources while providing for
meaningful tobacco sales
enforcement. The bill passed the
House (136-0) and Senate (44-0) in
the final hours of the session and was
signed into law May 17.
     House Bill 661 – Secondhand
Smoke Exposure to Foster
Children.  For the second
consecutive year, a bill was
introduced that would require the
Social Services Administration (SSA)
to adopt regulations requiring foster
care parents to protect children in their
care from exposure to secondhand
smoke. Delegate Cardin and fourteen
co-sponsors supported the initiative.
Despite a positive hearing—including
testimony from the Maryland
Department of Human Resources in
support of the measure—the bill was
unable to overcome fears of negatively
impacting the already limited quantity of
foster homes, and received an
unfavorable report by the Judiciary
Committee. Notwithstanding the
legislative defeat, the SSA, under the
new O’Malley Administration, has
pledged to take up the issue via
regulations, a move applauded by
members of the Committee.
     House Bill 288/House Bill 754 –
Tobacco Tax for Health Care
Initiative.   Several pieces of
legislation were introduced in an effort
to expand health care coverage to the
uninsured. While differing in how the
money raised was to be spent, the two
most prominent bills sought to increase
the state’s current cigarette tax by $1 in
order to fund this expansion. The
original proposal - HB 288 – Healthy
Maryland Initiative – was driven by the
Maryland Health Care For All
Coalition. While the Coalition was able
to garner significant support for the
concept,  its specific proposal was not
voted on in committee. Instead, the
Health and Government Operations
Committee passed a similar tobacco
tax bill sponsored by Delegate and
Committee Chairman Pete Hammon.
That bill – HB 754 – Children and
Working Families Health Care Act –
passed the House (102-37) but died in
the Senate where the bill was never
Continued from page 6
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voted on.  The leadership instead
decided to include the proposal as
part of a broad-based tax package
that would address the State’s
current fiscal crisis without relying
solely on a cigarette tax, which is
viewed as a declining revenue
source.
    The tobacco control community
greatly cheered the results of the
2007 General Assembly Session.
The successful passage of numerous
high-profile laws will not only
improve the health and safety of all
Marylanders, but will free advocates
to work on other pressing issues in
tobacco control.
Continued from page 7
Report Considers
Assessment of PREPs and
Center Staff Attend
Follow-up Meeting
On the heels of the Center’s  symposium (see lead story of this issue), the Life
Sciences Research Office (LSRO), a
nonprofit organization in Bethesda,
Maryland, released its report
Scientific Methods to Evaluate
Potential Reduced-Risk Tobacco
Products. The latest in a series by
the LSRO’s Reduced Risk Review
Project, the report outlines a
comprehensive, science-based
approach for assessing the health
effects of potential reduced exposure
tobacco products (PREPs) in
individuals who use such products as
a substitute for smoking conventional
cigarettes.
     Some of the LSRO conclusions
are: (1) there exist reliable testing and
assessment methods for individual
risk reduction to conduct pre-market
evaluation of PREPs; (2) these
methods should focus on lung cancer,
chronic obstructive pulmonary
disease, and cardiovascular disease,
as these health effects are measurable
and cause 90 percent of annual
smoking-related deaths; (3)
preclinical and clinical testing data are
needed to evaluate PREP risk
reduction in individual smokers; (4)
risk assessment can be used to
evaluate PREPs; (5) clinical,
behavioral, and epidemiologic
methods are needed to determine the
effects of a PREP on population risk;
and (6) post-marketing evaluations of
population risk are necessary to
obtain sufficient and reliable data to
assess potential unintended public
health consequences.
     Philip Morris USA provided
funding for the report.  For more
information and to view the executive
summary, visit http://www.lsro.org/
articles/rrrvw_report_042407.html.
     On June 5 and 6, 2007, Center
Director Kathleen Dachille and
Research Fellow Jackie McNamara
attended the LSRO’s committee
meeting on differentiating health risks
for categories of tobacco products,
specifically smokeless tobacco. In
addition to a briefing on the process
that culminated in the LSRO
report, panel experts spoke about
the health and biological effects of
Swedish snus1 compared to
cigarette smoking, and the
chemistry of smokeless versus
combustible tobacco products.
     The overall objectives of the
differentiating health risks project
are: (1) to review data on product
characteristics, chemistry,
biological activity, toxicology,
human exposure, and biological
effects associated with the risk of
disease for smokeless tobacco
products; and (2) to identify
similarities and differences
between smokeless tobacco
products that have been
demonstrated to pose less risk of
harm than conventional cigarettes.
Another LSRO report is expected
to be published in the second
quarter of 2008.
     To track the project’s
progress, refer to the LSRO
website at http://www.lsro.org/dtr/
dtr_home.html. For project-
specific questions, contact project
leader Daniel Byrd, Ph.D. at
byrdd@lsro.org.
(Endnotes)
1
 Swedish snus is a spitless,
noncombustible tobacco product
encased in a pouch that the user
places between the lip and gum.
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INSIDE THE
CENTER
Center Hosts Third Annual
Tobacco Enforcement
Conference
On June15, 2007, the Center  for Tobacco Regulation hosted its third annual
tobacco enforcement conference at
the University of Maryland School of
Law. The conference drew more
than 30 attendees, including
members of the Attorney General’s
(AG’s) Office, Comptroller’s Office,
and Department of Health and
Mental Hygiene, and representatives
from the local health departments
and police departments of thirteen
jurisdictions, including those from the
State’s furthest localities (Garrett
County to the west and Worcester
County to the east). This annual
conference focuses on enforcement
issues that arise as local jurisdictions
develop and implement programs to
enforce tobacco control laws, such
as laws prohibiting tobacco sales to
minors, banning smoking in public
places and prohibiting youth use or
possession of tobacco products. The
conference is designed to facilitate
the use of best practices in
enforcement across the state.
     The conference opened with a
review of existing law on entrapment
and a discussion of which
compliance- check procedures
would not violate this legal defense.
Essentially, Center Director Kathleen
Dachille described when and how a
minor hired by the local jurisdiction
may lie when attempting to make a
tobacco purchase during a sting
operation. Dachille then led a lively
Q & A session, allowing participants
to flesh out the circumstances giving
rise to entrapment claims in two
local jurisdictions. Local health
department and law enforcement
employees are now prepared to
consider changes to current
compliance- check procedures
which may become necessary as
programs age and retailers become
more aware of current inspection
protocols.
     Next on the agenda was a
review of recent enforcement
developments at both the local and
state level by Deputy Director
Michael Strande.  Strande reviewed
two local tobacco control laws (a
product placement and a civil sales
to minors provision) passed by the
General Assembly on behalf of three
local jurisdictions. Strande discussed
the benefits of such laws and their
availability to all counties, including
those with traditional commissioner
forms of government. Participants
were provided with copies of those
bills and encouraged to contact the
Center if they desire to establish a
similar local law.
     Strande’s presentation was
followed by a discussion of
Maryland’s newly enacted clean
indoor air law. With a substantial
amount of the enforcement
responsibility to be delegated to
local health departments,
representatives were interested in
learning as much as they could about
the implementation regulations
currently being drafted by the
Department of Labor, Licensing and
Regulation and the Department of
Health and Mental Hygiene. Strande
discussed the law’s implications for
current businesses, specifically
focusing on what the new law will
mean for the growing phenomenon
of hookah bars. Strande received
some excellent suggestions for the
regulatory drafting committee.
     A question about the licensing of
tobacco retailers allowed Dachille to
segue into a review of license
suspension or revocation of a
retailer’s tobacco license. While the
possibility of locals gaining control of
tobacco retailer licenses remains
“open but murky,” as described by
Comptroller representatives,
Dachille also explained how to use
the current system to achieve license
suspensions for those stores that
repeatedly sell tobacco to kids.
Dachille described how the
relationship between local tobacco
enforcement and the Comptroller
has netted numerous license
suspensions over the last year. Local
health department and law
enforcement employees were
encouraged to continue working
with the Comptroller or to contact
the Center for assistance in setting
up a referral program.
     Continuing with the theme of
inter-agency coordination, Dachille
turned the floor over to Marlene
Trestman, Special Assistant to the
Attorney General, who described
the AG’s current efforts to combat
tobacco industry attempts to attract
and addict kids. Specifically,
Trestman requested the group’s
assistance in identifying illegal
tobacco sales at specific retail
Continued on page 10
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chains. These retailers had entered
into legally binding agreements
(assurances of voluntary
compliance) with the state. If the AG
could prove continued violations, it
could then pressure institutional
changes or ultimately bring suit. The
needed information, which is already
acquired during compliance checks,
could be tracked and forwarded to
the AG, generating greater
compliance without increased cost.
     After a half day of discussion, the
conference concluded with an
“open-mic” update, allowing
representatives of each county or
organization to describe their recent
tobacco control work. This not only
helped some of the geographically
isolated groups understand what
was happening across the State, but
allowed for a sharing of best
practices by those who had worked
through similar scenarios.
     Based on attendee feedback, the
conference succeeded in fostering
cooperative relationships among the
State’s law enforcement agencies
and provided a clear picture of
current tobacco control issues. For
conference materials, contact
Michael Strande at 410-706-1129
or mstrande@law.umaryland.edu.
Continued from page 9
Center Helps with FCTC
Implementation
In  its closing minutes on July 6,2007, the Second Conference of  the Parties (COP-II), the
governing body of the Framework
Convention on Tobacco Control
(FCTC), the world’s first public
health treaty negotiated by the World
150 representatives from 46
nations, was the first major FCTC
negotiation held outside Geneva,
Switzerland, where the WHO is
headquartered. South Africa has
offered to host COP-III in the fall of
2008. Advocates hope that
changing the meeting locations will
have a strong regional influence on
tobacco control policies. There is
also increasing support for
conducting future meetings in
smokefree cities, which would,
ironically, exclude Geneva at
present.
     The Conference also launched
negotiations on a protocol
addressing international cigarette
smuggling and voted on working
groups for a variety of other issues
addressed in the FCTC, such as
product regulation and labeling,
advertising, cessation, industry
interference, public education, and
financial assistance to developing
countries.
     “The work completed during the
interim between COP-I and COP-
II made many of the accomplish-
ments of COP-II possible,” said
Smith.  “It will be interesting to see if
the successes of COP-II will be
emulated at COP-III.” To learn
more about the FCTC and the
FCA, go to http://www.fctc.org.
Health Organization (WHO),
unanimously approved new guidelines
for protecting people worldwide from
tobacco smoke. The FCTC is a
roadmap to effective global, national,
and local tobacco control measures
intended to protect people from the
consequences of tobacco use and
exposure to secondhand smoke.
Implementing Article 8 of the FCTC,
the guidelines—which were drafted
over  a fifteen-month period by a
panel of experts—call for a total ban
on smoking in all indoor public places,
workplaces, and public transportation.
     Chris Bostic, Tobacco Control
Clinic Instructor, and Erin Smith,
Center Staff Attorney, attended COP-
II in Bangkok, Thailand, from June 30
to July 6. Bostic and Smith served as
delegates representing the Framework
Convention Alliance (FCA), a
confederation of over 250
nongovernmental organizations from
over 100 countries. The University of
Maryland School of Law is an
organizational member of the FCA,
whose mission is to advocate for
strong development and
implementation of the FCTC.
     “From the perspective of the FCA
and public health in general, COP-II
was an enormous success,” said
Bostic.  “Nearly every decision fell our
way, and the influence of the tobacco
industry has waned dramatically.  In
earlier negotiations, some governments
literally had tobacco industry
representatives in their official
delegations.  Now, many governments
choose members of the FCA as their
delegates, because they are widely
recognized as the true experts.”
     This meeting, attended by nearly
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R.J. Reynolds must pay $2.75million in punitive damages to  the family of a California
smoker who died from lung cancer
in 2000.1 The family of Leslie
Whiteley—who variably smoked
Camel and Marlboro cigarettes from
1972 at age thirteen until she was
diagnosed with lung cancer in
1998—will also receive nearly $2.5
million in compensatory damages.
     The jury in the wrongful death
suit unanimously found that both
Reynolds and Philip Morris
purposefully lied and made false
promises to Leslie Whiteley about
NATIONAL
NEWS
Did You Know?
 Jury Awards Damages to
Family of Deceased
Smoker
the dangers of their cigarettes. The
jury also found that the companies
intended for Whiteley to rely on
these misrepresentations, that she
reasonably relied on them, and that
this reliance was a substantial factor
in causing her harm.
     The jury was split on whether
defendants were guilty of
oppression, malice, or fraud in the
conduct that gave rise to the liability
findings. With a 9-3 vote in favor,
the jury met the legal requirement to
assess punitive damages against
Reynolds. However, the jury’s 8-4
vote in favor of assessing punitive
damages against Philip Morris fell
one vote short.
     The case began with a 2000 trial
in which a jury awarded the
Whiteleys $21.7 million in
compensatory and $20 million in
punitive damages. 2 Leslie Whiteley
died on July 3, 2000, about three
months after the initial verdict was
rendered. An appeals court reversed
the verdict in 2004, however, finding
that the trial court erred in failing to
instruct the jury that it was
prohibited from finding tobacco
companies liable for conduct
occurring from 1988 through 1997. 3
A California law then in effect (but
later repealed) specifically protected
tobacco companies against product
liability lawsuits brought by individual
smokers during that ten-year period.
(Endnotes)
1
 Whiteley v. R.J. Reynolds Tobacco Co.,
No. 303184 (Cal. Super. Ct., May 2, 2007
(verdict on liability) and May 9, 2007
(verdict on punitive damages)).  A copy
of the jury’s May 2 verdict is available at
http://tobacco.neu.edu/litigation/cases/
supportdocs/
whiteley_verdict_2007_compensatory.pdf.
2
 Whiteley v. Raysbesto-Manhattan,
Inc., No. 303184 (Cal. Super. Ct., Mar. 20,
2000 (verdict on liability) and  Mar. 27,
2000 (verdict on punitive damages))
(unreported).  To view San Francisco
Superior Court docket for No. 303184, see
http://www.sftc.org.
3
 Whiteley v. Philip Morris Inc., 117
Cal.App.4th 635, 11 Cal.Rptr.3d 807
(Cal.App. 1st Dist. Apr. 7, 2004), as
modified on denial of rehearing (No.
A091444,  Apr. 29, 2004).
Arkansas Plaintiffs May
Bring Light Cigarettes Suit
in State Court
The U.S. Supreme Courtunanimously rejected PhilipMorris’ claim that it was
“acting under a federal officer”
within the meaning of 28 U.S.C.
§1442(a)(1) when it tested and
marketed Cambridge Lights and
Marlboro Lights cigarettes to
consumers.  Watson v. Philip
Morris.1 Consequently, plaintiffs
who sued the tobacco company for
allegedly violating the Arkansas
Deceptive Trade Practices Act may
proceed with their lawsuit in
Arkansas state court, rather than
having to move it to federal court, a
typically less plaintiff-friendly venue.
     Section 1442(a)(1) allows
government officials and those acting
directly under them to remove to
federal court suits originally filed in
state court. In reversing the Eighth
Circuit Court of Appeals, the
Supreme Court rejected Philip
Twenty-two states haveenacted comprehensive cleanindoor air legislation that
includes restaurants and bars.
Recently enacted smoking bans in
several states will be phased in over
the next two years, with the last—
Montana’s—scheduled to go into
effect in October 2009.  New
Hampshire, New Mexico, Illinois,
and Oregon are among the latest
states to join the ever-expanding list.
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Morris’ claim that the tobacco
industry should receive the same
protection from state-court suits as
do private parties who act as
government contractors. Private
contractors do more than comply
with the laws that govern their
businesses; they assist the
government by producing needed
items or performing acts that the
government itself would have to
produce or perform in the absence
of a contract with the private entity.
     The Federal Trade Commission
(FTC) closely regulates the
advertising of light cigarettes by
requiring manufacturers to perform a
certain test to measure the amount of
tar and nicotine in those cigarettes
before making any claims that they
contain lower amounts of these
substances. The Court held that
Philip Morris’ compliance with this
scheme amounted to no more than
the typical relationship between a
regulated entity and regulatory
agency. Nor did the FTC “delegate
authority” over testing cigarettes for
tar and nicotine to the tobacco
industry, as Philip Morris claimed.
Rather than acting as direct agents of
the FTC, Philip Morris and the
tobacco industry in general were
simply highly regulated entities with
respect to the testing and advertising
of light cigarettes.
     This decision is likely to have a
major impact on class-action suits
concerning light cigarettes brought
under other states’ consumer-
protection laws.
(Endnotes)
1
 127 S.Ct. 2301 (June 11, 2007).   See also
Tobacco Regulation Review, Vol. 6, Issue
1 (Apr. 2007), at pp. 11-12.
Smokeless “Snus”
Products Test Marketed
Recent moves by R.J. Reynolds and Philip Morris   illustrate the cigarette
manufacturers’ desire to expand into
the smokeless tobacco market. On
July 1, 2007, Reynolds began test
marketing Camel Snus in five cities:
Columbus, OH; Indianapolis, IN;
Kansas City, MO; Orlando, FL; and
Raleigh, NC.1 Despite receiving
mixed results with Taboka —a
similar smokeless tobacco product
introduced in the Indianapolis area in
2006— Philip Morris began test
marketing Marlboro Snus in the
Dallas-Fort Worth area in August
2007.
     Snus (pronounced “snoose”)
differs from traditional spit tobacco,
commonly known as “dip” or
“chew,” in that it is encased in a
pouch that the user places between
the lip and gum for up to 30 minutes
and does not require spitting. The
products are purportedly aimed at
attracting adult smokers who are
seeking cigarette alternatives but
who do not care for the taste,
texture, or spitting associated with
dip or chew.2
     Marlboro Snus contains a “flavor
strip,” offered in four varieties: Rich,
Mild, Mint, and Spice. Similarly,
Camel Snus comes in three varieties:
Original, Frost, and Spice.
     The products are not advertised
as an alternative to cigarette smoking
in general, though Reynolds
specifically markets Camel Snus—
tagged as “Pleasure for
Wherever”—as a substitute for
cigarettes in areas where smoking is
prohibited, such as at concerts, on
airplanes, and in bars and
restaurants.3 Both manufacturers are
careful not to make health claims
about their products, 4 with Philip
Morris going so far as to state on its
website that smokeless tobacco
products are “not a safe alternative
to smoking.”5
     Despite these carefully crafted
statements, industry watchers have
noted a general push to market snus
and smokeless tobacco as so-called
reduced harm tobacco products.
Members of the tobacco control and
public health communities are clearly
at odds as to whether use of any
tobacco product should be
promoted as reducing harm, with
many arguing that a quit-only
approach is the only appropriate
public health message.
(Endnotes)
1 http://www.snuscamel.com/CSN/
dtclogin.jsp?brand=CSN (requires
log-in ID).
2 http://www.philipmorrisusa.com/
en/popup_marlboro_snus_fact_sheet.
asp?source=home_link.
3 http://www.snuscamel.com/CSN/
dtclogin.jsp?brand=CSN.
4 http://www.snuscamel.com/CSN/
dtc_faq.jsp?category=912&subject
= 913&question=964&preview
=false#22.
5 http://www.philipmorrisusa.com/
en/popupmarlboro_snus_fact_sheet.
asp?source=home_link.
